Not applicableLooking for participantsNCT05866757What this trial is testingDiscontinuation StudyWho this might be right forMultiple MyelomaCancerHematologic Cancer University College Cork 70
Not applicableStudy completedNCT05348395What this trial is testingMonocyte Priming When Consuming a Western DietWho this might be right forHeart Diseases Wake Forest University Health Sciences 8
Not applicableStudy completedNCT05387902What this trial is testingShort-term Outcomes of Elective High-risk PCI With Extracorporeal Membrane Oxygenation Support: a Single-centre RegistryWho this might be right forCoronary Artery Disease Robert Jan van Geuns 25
Not applicableStudy completedNCT05752188What this trial is testingPrognostic Value of Cardiovascular Risk of sST2 and Troponin I-hs in Patients With Acute Chest PainWho this might be right forAcute Chest PainAcute Coronary Syndrome Fondazione Policlinico Universitario Agostino Gemelli IRCCS 100
Early research (Phase 1)Study completedNCT00477035What this trial is testingPost-transplant Autologous Cytokine-induced Killer (CIK) Cells for Treatment of High Risk Hematologic MalignanciesWho this might be right forLeukemiaMultiple Myeloma Sally Arai 22
Not applicableUnknownNCT02016638What this trial is testingSleep Quality in Pregnancy and Its Impact on Pregnancy OutcomesWho this might be right forObstructive Sleep ApneaPregnancy Induced HypertensionHigh-Risk Pregnancy+2 more All India Institute of Medical Sciences 200
Not applicableStudy completedNCT01934426What this trial is testingIdentification of Admission High Risk ElderlyWho this might be right forPneumoniaUrinary Tract InfectionStroke National Taiwan University Hospital 760
Not applicableUnknownNCT01642849What this trial is testingEffect of Diet Composition on Weight Change and Metabolic ParametersWho this might be right forObesityInflammation University of Tennessee 24
Large-scale testing (Phase 3)Looking for participantsNCT07582835What this trial is testingStudy of the Long-term Effects of P2Y12 Inhibitor Monotherapy and Coagulation Markers After Percutaneous Coronary Angioplasty.Who this might be right forCoronary Artery DiseasePercutaneous Coronary InterventionAcute Coronary Syndromes+3 more Cardiocentro Ticino 355
Not applicableStudy completedNCT02955238What this trial is testingLatinos Understanding the Need for AdherenceWho this might be right forAtherosclerosisHigh Blood PressureType 2 Diabetes Mellitus+2 more San Diego State University 587
Not applicableStudy completedNCT00145756What this trial is testingChina Salt Substitute StudyWho this might be right forHypertensionCardiovascular Diseases The George Institute 600
Testing effectiveness (Phase 2)Study completedNCT02822222What this trial is testingSafety Study of RMJH-111b to Treat Essential HypertensionWho this might be right forEssential Hypertension RMJ Holdings, LLC 22
Not applicableUnknownNCT01633801What this trial is testingUse of High Flows in Pediatric Cardiac Surgical PatientsWho this might be right forCongenital Heart Disease Bambino Gesù Hospital and Research Institute 80
Post-approval studies (Phase 4)Study completedNCT00442845What this trial is testingEstablish The Benefits Of Using Various Starting Doses Of Atorvastatin On Achievement Of Cholesterol Targets (ACTFAST)Who this might be right forCoronary ArteriosclerosisDiabetes Mellitus, Type 2Cerebrovascular Accident+2 more Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 2,080
Not applicableUnknownNCT06542575What this trial is testingEfficacy of the Integration of Digital Therapeutics and Home-based Cardiac Rehabilitation in High-Risk Post-PCI PatientsWho this might be right forCoronary Artery DiseaseMyocardial Infarction West China Hospital 366
Not applicableStudy completedNCT02750644What this trial is testingPostapproval Trial On Carotid Stenting in Patients With High Risk Vs Standard Risk for Open Carotid Endarterectomy(REAL)Who this might be right forCarotid Artery Diseases Joaquin de Haro, M.D. 125
Testing effectiveness (Phase 2)Ended earlyNCT01534143What this trial is testingHigh Dose Busulfan and Bortezomib in Treating Patients With High Risk Multiple Myeloma Undergoing Stem Cell TransplantWho this might be right forRefractory Multiple MyelomaStage I Multiple MyelomaStage II Multiple Myeloma+1 more Barbara Ann Karmanos Cancer Institute 1
Post-approval studies (Phase 4)Study completedNCT01053910What this trial is testingRamipril 10 mg/Day PreventionWho this might be right forAtherosclerosis Sanofi 1,012
Not applicableStudy completedNCT04359446What this trial is testingLaser-excimer Versus High-pressure Dilation to Treat Under-expansion of the StentWho this might be right forCardiovascular DiseasesArterial Disease Fundación EPIC 31
Early research (Phase 1)Study completedNCT02332850What this trial is testingPhase Ib Study of SAR650984 in Combination With Carfilzomib for Treatment of Relapsed or Refractory Multiple MyelomaWho this might be right forMultiple Myeloma Thomas Martin, MD 83